Medifast, Inc.
MED
$10.53
$0.100.96%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.67M | 248.00K | 3.64M | -7.00M | 2.09M |
| Total Depreciation and Amortization | 14.24M | 13.96M | 13.70M | 12.73M | 12.71M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.10M | 1.39M | 3.11M | 21.32M | 19.42M |
| Change in Net Operating Assets | -9.81M | -8.41M | -16.30M | -6.45M | -9.75M |
| Cash from Operations | 6.86M | 7.19M | 4.15M | 20.60M | 24.48M |
| Capital Expenditure | -5.61M | -6.55M | -6.58M | -7.14M | -7.45M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.31M | -15.86M | -3.34M | -18.66M | -19.07M |
| Cash from Investing | -7.93M | -22.41M | -9.91M | -25.80M | -26.52M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.00K | 0.00 | 0.00 | 0.00 | 36.00K |
| Repurchase of Common Stock | -370.00K | -371.00K | -373.00K | -388.00K | -836.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -195.00K | -195.00K | -196.00K | -199.00K | -715.00K |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -564.00K | -566.00K | -569.00K | -587.00K | -1.52M |
| Foreign Exchange rate Adjustments | 4.00K | 0.00 | 4.00K | 32.00K | 47.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.63M | -15.78M | -6.32M | -5.75M | -3.51M |